Published in Dev Cell on August 28, 2014
Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol (2016) 0.95
Brain barriers: Crosstalk between complex tight junctions and adherens junctions. J Cell Biol (2015) 0.91
Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain (2015) 0.84
Optic Disc Edema Responding to Localized Anti-vascular Endothelial Growth Factor Treatment in a Patient with POEMS Syndrome. Korean J Ophthalmol (2015) 0.82
Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes. Proc Natl Acad Sci U S A (2016) 0.78
Vascular permeability--the essentials. Ups J Med Sci (2015) 0.77
Systems biology of the microvasculature. Integr Biol (Camb) (2015) 0.77
The blood-brain barrier and methamphetamine: open sesame? Front Neurosci (2015) 0.76
β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand. Arterioscler Thromb Vasc Biol (2015) 0.76
VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation. J Exp Med (2017) 0.75
Apicobasal polarity of brain endothelial cells. J Cereb Blood Flow Metab (2015) 0.75
Caveolins and caveolae in ocular physiology and pathophysiology. Prog Retin Eye Res (2016) 0.75
Endothelial MAPKs Direct ICAM-1 Signaling to Divergent Inflammatory Functions. J Immunol (2017) 0.75
Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease. Front Neurosci (2017) 0.75
Cellular survival: a play in three Akts. Genes Dev (1999) 17.05
Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol (1991) 8.67
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
VEGF is required for growth and survival in neonatal mice. Development (1999) 6.16
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol (2003) 5.74
Pathophysiological consequences of VEGF-induced vascular permeability. Nature (2005) 4.08
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med (2005) 3.60
Signal transduction by vascular endothelial growth factor receptors. Biochem J (2011) 3.47
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One (2008) 3.46
Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol (2009) 3.43
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36
Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis (2008) 2.99
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) (2005) 2.89
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol (1990) 2.23
Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med (2007) 2.19
Dynamics and functions of tight junctions. Trends Cell Biol (2010) 2.18
Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction. Nat Cell Biol (2010) 2.07
Biotinylation and assessment of membrane polarity: caveats and methodological concerns. Am J Physiol (1995) 2.02
Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology (2010) 1.92
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest (2012) 1.90
Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res (2000) 1.73
Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology (2012) 1.63
Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes (2010) 1.63
VEGF deprivation-induced apoptosis is a component of programmed capillary regression. Development (1999) 1.60
Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci (2002) 1.56
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ (2009) 1.52
Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci (1992) 1.50
Roles for VEGF in the adult. Microvasc Res (2007) 1.48
p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J (2002) 1.46
Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol (1996) 1.43
Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development (2005) 1.41
TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One (2009) 1.38
Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia (2010) 1.31
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med (2012) 1.31
Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. Circ Res (2005) 1.21
Role of shear-stress-induced VEGF expression in endothelial cell survival. J Cell Sci (2012) 1.21
Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes (2003) 1.20
Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem J (2002) 1.19
Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem (2007) 1.18
ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol Biol Cell (2008) 1.11
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res (2007) 1.11
Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS Lett (2002) 1.10
VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. Am J Pathol (2013) 1.07
Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels. J Cell Physiol (2008) 1.06
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis. Nat Commun (2012) 1.04
Regulation of cerebral microvascular permeability by histamine in the anaesthetized rat. J Physiol (1998) 1.02
Variable restriction of albumin diffusion across inflamed cerebral microvessels of the anaesthetized rat. J Physiol (1994) 1.01
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat Commun (2012) 1.00
Two components of blood-brain barrier disruption in the rat. J Physiol (1997) 1.00
Quantitative electron microscopic immunocytochemistry of neuroactive amino acids. Anat Embryol (Berl) (1989) 0.93
Basement membrane-dependent modification of phenotype and gene expression in human retinal pigment epithelial ARPE-19 cells. Invest Ophthalmol Vis Sci (2004) 0.92
Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology (2012) 0.89
Regulation of cerebromicrovascular permeability by lysophosphatidic acid. Microcirculation (2010) 0.86
Polarizing pathways: balancing endothelial polarity, permeability, and lumen formation. Exp Cell Res (2013) 0.82
A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg (2005) 0.81